These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 21508862)
1. Reduced brain-derived neurotrophic factor serum concentrations in acute schizophrenic patients increase during antipsychotic treatment. Lee AH; Lange C; Ricken R; Hellweg R; Lang UE J Clin Psychopharmacol; 2011 Jun; 31(3):334-6. PubMed ID: 21508862 [TBL] [Abstract][Full Text] [Related]
2. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Pirildar S; Gönül AS; Taneli F; Akdeniz F Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697 [TBL] [Abstract][Full Text] [Related]
3. Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. Grillo RW; Ottoni GL; Leke R; Souza DO; Portela LV; Lara DR J Psychiatr Res; 2007; 41(1-2):31-5. PubMed ID: 16546213 [TBL] [Abstract][Full Text] [Related]
4. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients. Miodownik C; Maayan R; Ratner Y; Lerner V; Pintov L; Mar M; Weizman A; Ritsner MS Clin Neuropharmacol; 2011; 34(4):155-60. PubMed ID: 21617527 [TBL] [Abstract][Full Text] [Related]
6. Effects of antipsychotics on the serum BDNF levels in schizophrenia. Chen CC; Huang TL Psychiatry Res; 2011 Oct; 189(3):327-30. PubMed ID: 21320726 [TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review. Martinotti G; Di Iorio G; Marini S; Ricci V; De Berardis D; Di Giannantonio M J Biol Regul Homeost Agents; 2012; 26(3):347-56. PubMed ID: 23034254 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. Lee BH; Kim YK Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464 [TBL] [Abstract][Full Text] [Related]
9. Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Reis HJ; Nicolato R; Barbosa IG; Teixeira do Prado PH; Romano-Silva MA; Teixeira AL Neurosci Lett; 2008 Jul; 439(2):157-9. PubMed ID: 18514407 [TBL] [Abstract][Full Text] [Related]
10. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. Yoshimura R; Hori H; Sugita A; Ueda N; Kakihara S; Umene W; Nakano Y; Shinkai K; Mitoma M; Ohta M; Shinkai T; Nakamura J Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1072-7. PubMed ID: 17459549 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Gama CS; Andreazza AC; Kunz M; Berk M; Belmonte-de-Abreu PS; Kapczinski F Neurosci Lett; 2007 Jun; 420(1):45-8. PubMed ID: 17442489 [TBL] [Abstract][Full Text] [Related]
12. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation. Pedrini M; Chendo I; Grande I; Lobato MI; Belmonte-de-Abreu PS; Lersch C; Walz J; Kauer-Sant'anna M; Kapczinski F; Gama CS Neurosci Lett; 2011 Mar; 491(3):207-10. PubMed ID: 21256922 [TBL] [Abstract][Full Text] [Related]
13. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine. Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084 [TBL] [Abstract][Full Text] [Related]
15. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia. Rizos EN; Michalopoulou PG; Siafakas N; Stefanis N; Douzenis A; Rontos I; Laskos E; Kastania A; Zoumpourlis V; Lykouras L Neuropsychobiology; 2010; 62(2):87-90. PubMed ID: 20523079 [TBL] [Abstract][Full Text] [Related]
16. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia. Zhang XY; Zhou DF; Wu GY; Cao LY; Tan YL; Haile CN; Li J; Lu L; Kosten TA; Kosten TR Neuropsychopharmacology; 2008 Aug; 33(9):2200-5. PubMed ID: 17987059 [TBL] [Abstract][Full Text] [Related]
17. The interplay between BDNF and oxidative stress in chronic schizophrenia. Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Okusaga OO; Zunta-Soares GB; Soares JC Psychoneuroendocrinology; 2015 Jan; 51():201-8. PubMed ID: 25462893 [TBL] [Abstract][Full Text] [Related]